{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:27:53Z","timestamp":1787149673666,"version":"build-2736575974"},"reference-count":22,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2025,7,29]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1136\/ejhpharm-2024-004425","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T17:20:13Z","timestamp":1754932813000},"page":"479-482","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Optimisation of voriconazole treatment in paediatric patients with\n                    <i>Aspergillus flavus<\/i>\n                    fungal endocarditis: a pharmacokinetics case report"],"prefix":"10.1136","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2256-3595","authenticated-orcid":false,"given":"Mario","family":"Rodenas-Rovira","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Gil-Candel","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Burgos-Berjillos","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Montoya-Tamayo","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garcia-Pellicer","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Poveda-Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"2026081906551068000_33.5.479.1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/IDR.S393917","article-title":"Pacemaker Associated Aspergillus fumigatus Endocarditis: A Case Report","volume":"16","author":"Chen","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2026081906551068000_33.5.479.2","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00019-23","article-title":"Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management","volume":"36","author":"Thompson","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"2026081906551068000_33.5.479.3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.33963\/KP.14869","article-title":"Fungal endocarditis: what do we know in 2019?","volume":"77","author":"Ammannaya","year":"2019","journal-title":"Kardiol Pol"},{"key":"2026081906551068000_33.5.479.4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1017\/S1047951117000506","article-title":"Fungal endocarditis in paediatrics: a review of 192 cases (1971-2016)","volume":"27","author":"Ganesan","year":"2017","journal-title":"Cardiol Young"},{"key":"2026081906551068000_33.5.479.5","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000009"},{"key":"2026081906551068000_33.5.479.6","first-page":"252","article-title":"Fungal Endocarditis","volume":"31","author":"Yuan","year":"2016","journal-title":"Braz J Cardiovasc Surg"},{"key":"2026081906551068000_33.5.479.7","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1093\/eurheartj\/ehad625","article-title":"Correction to: 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM)","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"2026081906551068000_33.5.479.8","doi-asserted-by":"crossref","first-page":"T50","DOI":"10.1016\/j.farma.2022.12.008","article-title":"[Translated article] Therapeutic drug monitoring of voriconazole in a rapid-metabolizer patient with invasive pulmonary aspergillosis","volume":"47","author":"Esquivel Negr\u00edn","year":"2023","journal-title":"Farm Hosp"},{"key":"2026081906551068000_33.5.479.9","unstructured":"Blanco Dorado S . BOLET\u00cdN DE CASOS CL\u00cdNICOS PK \/ PG. In: Sociedad Espa\u00f1ola de Farmacia Hospitalaria, Bolet\u00edn casos cl\u00ednicos Sociedad Espa\u00f1ola de Farmacia Hospitalaria. 2021: 1\u201313."},{"key":"2026081906551068000_33.5.479.10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01540-12"},{"key":"2026081906551068000_33.5.479.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06050-1"},{"key":"2026081906551068000_33.5.479.12","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00683-23","article-title":"Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis","volume":"67","author":"Stemkens","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2026081906551068000_33.5.479.13","unstructured":"AEMPS . Voriconazol datasheet. AEMPS CIMA; 2023. Available: https:\/\/cima.aemps.es\/cima\/publico\/detalle.html?nregistro=80652"},{"key":"2026081906551068000_33.5.479.14","unstructured":"AEMPS . Amphotericin B datasheet. AEMPS CIMA; 2024. Available: https:\/\/cima.aemps.es\/cima\/publico\/detalle.html?nregistro=61117"},{"key":"2026081906551068000_33.5.479.15","first-page":"13","article-title":"The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on propofol pharmacokinetics in children","volume":"13","author":"Pavlovic","year":"2020","journal-title":"Pharmgenomics Pers Med"},{"key":"2026081906551068000_33.5.479.16","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5497427","article-title":"Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis","volume":"2021","author":"Yousefian","year":"2021","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2026081906551068000_33.5.479.17","doi-asserted-by":"crossref","first-page":"106506","DOI":"10.1016\/j.ejps.2023.106506","article-title":"Prediction of plasma trough concentration of voriconazole in adult patients using machine learning","volume":"188","author":"Cheng","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"2026081906551068000_33.5.479.18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00626-12"},{"key":"2026081906551068000_33.5.479.19","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342090-00003"},{"key":"2026081906551068000_33.5.479.20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cpt.583","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy","volume":"102","author":"Moriyama","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"2026081906551068000_33.5.479.21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/DHPS.S140213","article-title":"A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis","volume":"9","author":"Ferguson","year":"2017","journal-title":"Drug Healthc Patient Saf"},{"key":"2026081906551068000_33.5.479.22","doi-asserted-by":"crossref","first-page":"T234","DOI":"10.1016\/j.farma.2024.02.013","article-title":"[Translated article] Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP)","volume":"48","author":"Luque","year":"2024","journal-title":"Farm Hosp"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2024-004425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:55:21Z","timestamp":1787147721000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2024-004425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,8,19]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/ejhpharm-2024-004425"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2024-004425","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}